Non-Hodgkin’s LymphomasAndrew D. Zelenetz, Furhan Yunus, Leo I. Gordon et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 329
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal eventsMitchell R. Smith, Karim Fizazi, Robert E. Coleman et al.|Annals of Oncology|2014Cited by 145
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristicsAllan Lipton, Ada Braun, Karim Fizazi et al.|European Journal of Cancer|2015Cited by 114
Early Generated B-1–Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma–like Neoplasia in Aged MiceKyoko Hayakawa, Richard R. Hardy, Anthony M. Formica et al.|The Journal of Immunology|2018Cited by 15
Analyses of circulating tumor cell (CTC) dynamics and treatment response in prostate cancer using the CTC-chip microfluidic deviceR.J. Lee, Daniel A. Haber, Shannon L. Stott et al.|Journal of Clinical Oncology|2009Cited by 1